by Guest Blogger, Angela Carmichael, MBA, RHIA, CCS, CCS-P
Although CMS intended to remain budget neutral (or no impact on reimbursement) changes in reimbursement is inevitable when you consider the difference between ICD-9-CM and ICD-10-CM/PCS. But make no mistake, the transition to ICD-10 introduces financial risk for both providers and payers that could be favorable for one and unfavorable for the other. Let’s take a closer look at the impact by area:
ICD-10 Impact on Medicare Reimbursement
- Goal of revenue neutrality in the short term
- No significant redistribution of payments across hospitals if claims are accurately coded
- Improve Medicare solvency in the long term
- Once sufficient ICD-10-CM/PCS data is available, expect CMS to further stratify payments using MS-DRGs
- Current missed opportunities with MS-DRG’s resulting from inadequate clinical documentation and/or inaccurate ICD-9-CM coding will continue & actually increase under ICD-10-CM/PCS
ICD-10 Impact on Medicaid Reimbursement
- Expect revenue neutrality in the short term
- Some Medicaid programs are lagging behind in preparing for 5010 & ICD-10-CM/PCS
- Goal is cost savings as the Medicaid ranks are swelling due to the economy and expansion of healthcare to the uninsured via healthcare reform
- Once sufficient ICD-10-CM/PCS data is available, expect state Medicaid programs to further stratify payments using whatever payment schemes they chose to utilize
ICD-10 Impact on Commercial Reimbursement
- They have experience with, and knowledge of, ICD-10-CM/PCS beyond that of the providers which creates an opportunity for them having a strategic advantage
- Mute regarding how they plan to utilize ICD-10 specificity
- May not remain revenue neutral during the transition like Medicare

Hi…
I’m curious as to what you mean by your statement that “missed opportunities with MS-DRG’s resulting from inadequate clinical documentation and/or inaccurate ICD-9-CM coding will CONTINUE & ACTUALLY INCREASE under ICD-10-CM/PCS?”
What are these missed opportunities?